AI assistant
Axogen, Inc. — Director's Dealing 2017
Jan 3, 2017
32414_dirs_2017-01-03_55024cd3-4b74-4bb1-89fb-52335e2a8c01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2016-12-29
Reporting Person: Zaderej Karen L. (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-29 | Common Stock | A | 40000 | — | Acquired | 282147 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-29 | Employee Stock Option (right to purchase) | $8.95 | A | 209500 | Acquired | 2026-12-29 | Common Stock (209500) | Direct |
Footnotes
F1: Represents shares underlying retention-based restricted stock units, all of which shall become vested on January 1, 2020 so long as the reporting person's employment is continuous from December 29, 2016 through January 1, 2020.
F2: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.